ChemBioFrance offers smart collections of bioactive molecules, partnerships for the production of analogues, screening, database analysis, as well as ADME and toxicity services to develop new molecules.
Submit a project request
ChemBioFrance offers to academic or private researchers, resources, equipments, services and expertises for the identification and characterization of biologically active molecules, as well as for their development towards pharmacological tools or their use in the fields of the environment, cosmetics, human and animal health.
Design and analysis of chemical libraries for screening. Analysis of screening data. Virtual screening (2D and 3D similarity, pharmacophore, docking). Bioprofiling of bioactive molecules (target prediction). Calculation and prediction of physicochemical properties (e.g. solubility, logP).
↗
Over 90,000 compounds and 16,000 original extracts, diverse and minimally tested. Sub-libraries available to your projects. Packaging designed for high-throughput screening. Simple, fast procedures that respect intellectual property rights.
↗
Evaluation of the pharmacokinetic properties of bioactive molecules. Analysis of molecular properties, in vitro cell tests, in vivo studies (pharmacokinetics, distribution, etc.).
↗
A network of screening platforms spread across the country. Expertise in molecular and cellular screening. Optimised procedures to guarantee quality, reproducibility and robustness of results.
↗
ChemBiofrance will organize its 7th annual meeting in Reims (19-20 May 2026). ...
The Societé de Chimie Therapeutique (SCT) and ChemBioFrance are proud to jointly propose a one day meeting on the advances in screening technologies for drug discovery. This Sympos...
Currently, around 3 million people in France are affected by a rare disease, and approximately 95% of these patients lack any available therapeutic options. This call aims to supp...
